Saliva-Based Detection of SARS-CoV-2

Saliva-based testing has emerged as a non-invasive, accessible alternative to nasopharyngeal swabs for the detection of SARS-CoV-2. The oral cavity serves as both a site of viral replication and a reservoir for viral particles, enabling self-collection of specimens outside traditional clinical settings. Key analytical approaches include reverse transcription polymerase chain reaction (RT-PCR), isothermal amplification methods, antigen detection and next-generation sequencing. Compared with invasive swabs, saliva sampling reduces discomfort, mitigates biohazard risk to healthcare workers and supports mass screening in community or workplace programmes. Challenges include variability in specimen quality, the presence of inhibitors, optimal sample transport and the need for robust RNA extraction or direct-to-assay protocols. Recent technological innovations have focused on on-site viral inactivation, simplified nucleic acid preparation and point-of-care platforms. Collectively, saliva-based diagnostics offer a powerful tool for early case identification, longitudinal monitoring of viral load and surveillance of emerging variants at scale.

Research from Nature Portfolio

Recent studies have demonstrated that saliva outperforms both nasopharyngeal and self-administered nasal swabs in identifying asymptomatic and mild infections. In a large cohort, saliva specimens yielded the highest positivity rate and displayed lower cycle threshold values during early infection, indicating higher viral loads. Integration with amplicon-based sequencing revealed strong concordance between genome coverage and RT-PCR metrics, enabling phylogenetic analysis of circulating lineages directly from saliva. These findings underscore saliva’s sensitivity and versatility as a sample type for both diagnostic testing and genomic surveillance, supporting its adoption in decentralised testing programmes.

Saliva-Based Detection of SARS-CoV-2 publication trend

The graph below shows the total number of articles in saliva-based detection of sars-cov-2 across all publications each year (not limited to Nature Index journals).

Technical terms

Reverse transcription polymerase chain reaction (RT-PCR): A laboratory method that converts viral RNA into DNA and amplifies specific genomic regions to detect the presence of SARS-CoV-2.

Reverse transcription loop-mediated isothermal amplification (RT-LAMP): An isothermal nucleic acid amplification technique that enables rapid detection of viral RNA at a constant temperature without specialised thermocyclers.

Cycle threshold (Ct): The number of amplification cycles required for the fluorescence signal in RT-PCR to exceed a predefined threshold, inversely proportional to the amount of target RNA in the sample.

Point-of-care assay: A diagnostic test designed for use at the site of patient care, providing rapid results without the need for centralised laboratory infrastructure.

References

1. Recent advances in RNA sample preparation techniques for the detection of SARS-CoV-2 in saliva and gargle. TrAC Trends in Analytical Chemistry (2023).
2. Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription–Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19. Journal of Clinical Microbiology (2020).
3. Saliva: potential diagnostic value and transmission of 2019-nCoV. International Journal of Oral Science (2020).
4. Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2. Emerging Microbes & Infections (2020).
5. Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection. Scientific Reports (2021).